Founded in 2021, Life Science REIT began with Ironstone Asset Management and entered public markets through an AIM flotation before later trading on the London Stock Exchange Main Market. The company invests in a diversified portfolio of UK properties that are leased, or intended to be leased, to tenants operating in the life science sector, with an investment objective centred on total return, capital growth and income. Its portfolio and investor materials point to a business built around specialist life science real estate, including assets linked to laboratory, research and related workspace needs. Recent company updates also show ongoing management of property, rental and occupancy metrics within that specialist segment.